RxDoctor Payments Data

Andres Schanzer, MD

Vascular Surgery · Worcester, MANPI 1073594933

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Cook Incorporated accounts for 79.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $23,442 and has fallen 72.7% since, to $6,398 in 2025. Among vascular surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$84,258in general payments, 2019–2025

Across 124 payments — averaging $679.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$67K
  • Cook Medical LLC$7K
  • Philips North America LLC$5K
  • Artivion, Inc.$5K
  • Abbott$185
  • Silk Road Medical, Inc.$152
  • plus $351 from 5 others
$542,502in research payments, 2019–2025

Across 121 payments — averaging $4483.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cook Research Incorporated$411K
  • Philips North America LLC$124K
  • Bolton Medical Inc$8K

What the payments were for

  • Consulting fees$48,66858%
  • Speaking & faculty fees$24,17329%
  • Travel & lodging$6,6828%
  • Food & beverage$4,7366%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$84,258 in reported general payments places this provider in the 95th percentile of 142 vascular surgery providers in Massachusetts.

See all vascular surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$267,811
Medicare patients
1,426
Services billed
2,024

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →